Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis (2024)

References

  • Arnold LD, Calderwood DJ, Dixon RW, Johnston DN, Kamens JS, Munschauer R, Rafferty P, Ratnofsky SE . 2000 Bioorg. Med. Chem. Lett. 10: 2167–2170

  • Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA . 2000 Mol. Cell. Biol. 20: 9018–9027

  • Bowman T, Garcia R, Turkson J, Jove R . 2000 Oncogene 19: 2474–2488

  • Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K, Herrmann R, Lynch KP, Hughes TP . 2002 Blood 99: 3472–3475

  • Briggs SD, Sharkey M, Stevenson M, Smithgall TE . 1997 J. Biol. Chem. 272: 17899–17902

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O . 1998 Blood 91: 3734–3745

  • Cortez D, Stoica G, Pierce JH, Pendergast AM . 1996 Oncogene 13: 2589–2594

  • Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830

  • Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M . 1996 Cancer Res. 56: 3589–3596

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • de Groot RP, Raaijmakers JA, Lammers JW, Koenderman L . 2000 Mol. Cell Biol. Res. Commun. 3: 299–305

  • Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . 2001 N. Engl. J. Med. 344: 1031–1037

  • Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . 1996 Nat. Med. 2: 561–566

  • Feller SM . 2001 Oncogene 20: 6348–6371

  • Feller SM, Knudsen B, Hanafusa H . 1995 Oncogene 10: 1465–1473

  • Furstoss O, Dorey K, Simon V, Barila D, Superti-Furga G, Roche S . 2002 EMBO J. 21: 514–524

  • Gambacorti-Passerini C, Barni R, le Coutre P, Zucchetti M, Cabrita G, Cleris L, Rossi F, Gianazza E, Brueggen J, Cozens R, Pioltelli P, Pogliani E, Corneo G, Formelli F, d'Incalci M . 2000 J. Natl. Cancer Inst. 92: 1641–1650

  • Garcia R, Yu C-L, Hudnall A, Catlett R, Nelson K, Smithgall TE, Fujita DJ, Ethier S, Jove R . 1998 Cell Growth Differ. 8: 1267–1276

  • Gesbert F, Griffin JD . 2000 Blood 96: 2269–2276

  • Goga A, McLaughlin J, Afar DEH, Saffran DC, Witte ON . 1995 Cell 82: 981–988

  • Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880

  • Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA . 1996 J. Biol. Chem. 271: 695–701

  • Hoover RR, Gerlach MJ, Koh EY, Daley GQ . 2001 Oncogene 20: 5826–5835

  • Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Moral LB, Niu G, Sinibaldi D, Bai F, Kraker AJ, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla KN, Loughran T, Wu J, Jove R . 2002 Oncogene, in press

  • Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Neiderwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B, Goldman J, O'Brien SG, Russell N, Fischer T, Ottmann O, Cony-Makhoul P, Facon T, Stone R, Miller C, Tallman M, Brown R, Schuster M, Loughran T, Gratwohl A, Mandelli F, Saglio G, Lazzarino M, Russo D, Baccarani M, Morra E . 2002 N. Engl. J. Med. 346: 645–652

  • Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F . 1989 J. Cell. Physiol. 140: 323–334

  • Klein E, Ben Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A, Vanky F . 1976 Int. J. Cancer 18: 421–431

  • Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE, Skorski T . 2002 EMBO J. in press

  • Li J, Smithgall TE . 1998 J. Biol. Chem. 273: 13828–13834

  • Lionberger JM, Wilson MB, Smithgall TE . 2000 J. Biol. Chem. 275: 18581–18585

  • Liu J, Campbell M, Guo JQ, Lu D, Xian YM, Andersson BS, Arlinghaus RB . 1993 Oncogene 8: 101–109

  • Liu Y, Bishop A, Witucki L, Kraybill B, Shimizu E, Tsien J, Ubersax J, Blethrow J, Morgan DO, Shokat KM . 1999 Chem. Biol. 6: 671–678

  • Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS . 1981 Proc. Soc. Exp. Biol. Med. 166: 546–550

  • Lugo TG, Witte ON . 1989 Mol. Cell. Biol. 9: 1263–1270

  • Martin P, Papayannopoulou T . 1982 Science 216: 1233–1235

  • McGlade J, Cheng A, Pelicci G, Pelicci PG, Pawson T . 1992 Proc. Natl. Acad. Sci. USA 89: 8869–8873

  • McLaughlin J, Chianese E, Witte ON . 1987 Proc. Natl. Acad. Sci. USA 84: 6558–6562

  • Morgan MA, Dolp O, Reuter CW . 2001 Blood 97: 1823–1834

  • Muller AJ, Young JC, Pendergast AM, Pondel M, Landau RN, Littman DR, Witte ON . 1991 Mol. Cell. Biol. 11: 1785–1792

  • Nagar B, Bornmann WG, Pellicena P, Schindler T, Veach DR, Miller WT, Clarkson B, Kuriyan J . 2002 Cancer Res. 62: 4236–4243

  • Neshat MS, Raitano AB, Wang HG, Reed JC, Sawyers CL . 2000 Mol. Cell. Biol. 20: 1179–1186

  • Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242

  • Nowell PC, Hungerford DA . 1960 Science 132: 1497

  • Oetzel C, Jonuleit T, Gotz A, van der Kuip H, Michels H, Duyster J, Hallek M, Aulitzky WE . 2000 Clin. Cancer Res. 6: 1958–1968

  • Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H . 1985 Blood 66: 1384–1392

  • Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792

  • Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML . 1993 Cell 75: 175–185

  • Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM . 1999 Genes Dev. 13: 2400–2411

  • Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T . 1994 EMBO J. 13: 764–773

  • Raitano AB, Halpern JR, Hambuch TM, Sawyers CL . 1995 Proc. Natl. Acad. Sci. USA 92: 11746–11750

  • Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL, Van Etten RA . 2002 Proc. Natl. Acad. Sci. USA 99: 10700–10705

  • Rowley JD . 1973 Nature 243: 290–293

  • Sattler M, Salgia R . 1998 Leukemia 12: 637–644

  • Sawyers CL . 1999 N. Engl. J. Med. 340: 1330–1340

  • Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ . 2002 Blood 99: 3530–3539

  • Sawyers CL, McLaughlin J, Witte ON . 1995 J. Exp. Med. 181: 307–313

  • Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J . 2000 Science 289: 1938–1942

  • Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, Kuriyan J . 1999 Mol. Cell 3: 639–648

  • Senechal K, Halpern J, Sawyers CL . 1996 J. Biol. Chem. 271: 23255–23261

  • Shuai K, Halpern J, ten Hoeve J, Rao XP, Sawyers CL . 1996 Oncogene 13: 247–254

  • Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . 2000 Blood 95: 2118–2125

  • Skorski T, Bellacosa A, Nieborowska-Skorska MN, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B . 1997 EMBO J. 16: 6151–6161

  • Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B, Calabretta B . 1998 Blood 91: 406–418

  • Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM, Sawyers CL . 2002 Blood 99: 1928–1937

  • Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R . 1999 Mol. Cell. Biol. 19: 7519–7528

  • Turkson J, Bowman TL, Garcia R, Caldenhoven E, de Groot RP, Jove R . 1998 Mol. Cell. Biol. 18: 2545–2552

  • Waller CF, Ali M, Heinzinger M, Lange W . 2000 Anticancer Res. 20: 809–814

  • Warmuth M, Bergmann M, Priess A, Hauslmann K, Emmerich B, Hallek M . 1997 J. Biol. Chem. 272: 33260–33270

  • Warmuth M, Danhauser-Riedl S, Hallek M . 1999 Ann. Hematol. 78: 49–64

  • Weisberg E, Griffin JD . 2000 Blood 95: 3498–3505

  • Woessmann W, Mivechi NF . 2001 Exp. Cell Res. 264: 193–200

Download references

Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis (2024)
Top Articles
Latest Posts
Article information

Author: Rob Wisoky

Last Updated:

Views: 5441

Rating: 4.8 / 5 (68 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Rob Wisoky

Birthday: 1994-09-30

Address: 5789 Michel Vista, West Domenic, OR 80464-9452

Phone: +97313824072371

Job: Education Orchestrator

Hobby: Lockpicking, Crocheting, Baton twirling, Video gaming, Jogging, Whittling, Model building

Introduction: My name is Rob Wisoky, I am a smiling, helpful, encouraging, zealous, energetic, faithful, fantastic person who loves writing and wants to share my knowledge and understanding with you.